Patents by Inventor Mark Sloan

Mark Sloan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240053324
    Abstract: Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.
    Type: Application
    Filed: September 6, 2023
    Publication date: February 15, 2024
    Inventors: Michael R. Love, Michael J. Fullmer, Kurt E. Leno, Xuandong Hua, Mark Sloan, Lei He, Glenn Berman
  • Patent number: 11789008
    Abstract: Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: October 17, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Michael R. Love, Michael J. Fullmer, Kurt E. Leno, Xuandong Hua, Mark Sloan, Lei He, Glenn Berman
  • Publication number: 20230199069
    Abstract: Systems, devices, and methods are provided for the management of multiple sensor control devices and/or multiple reader devices in an in vivo analyte monitoring environment, and also for resolving conflicts when merging data collected by different reader devices.
    Type: Application
    Filed: February 14, 2023
    Publication date: June 22, 2023
    Inventors: Mark Sloan, Nathan C. Crouther, Glenn Berman, Gil Porat, Michael R. Love
  • Publication number: 20230145119
    Abstract: Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.
    Type: Application
    Filed: October 17, 2022
    Publication date: May 11, 2023
    Inventors: Michael R. Love, Michael J. Fullmer, Kurt E. Leno, Xuandong Hua, Mark Sloan, Lei He, Glenn Berman
  • Patent number: 11563812
    Abstract: Systems, devices, and methods are provided for the management of multiple sensor control devices and/or multiple reader devices in an in vivo analyte monitoring environment, and also for resolving conflicts when merging data collected by different reader devices.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: January 24, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Mark Sloan, Nathan C. Crouther, Glenn Berman, Gil Porat, Michael R. Love
  • Publication number: 20230001090
    Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 5, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
  • Publication number: 20220263905
    Abstract: Systems, devices, and methods are provided for the management of multiple sensor control devices and/or multiple reader devices in an in vivo analyte monitoring environment, and also for resolving conflicts when merging data collected by different reader devices.
    Type: Application
    Filed: May 5, 2022
    Publication date: August 18, 2022
    Inventors: Mark Sloan, Nathan C. Crouther, Glenn Berman, Gil Porat, Michael R. Love
  • Publication number: 20220118180
    Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.
    Type: Application
    Filed: January 3, 2022
    Publication date: April 21, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
  • Publication number: 20220116395
    Abstract: Systems, devices, and methods are provided that allow the authentication of devices within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a reader device for communicating with the sensor control device. The analyte monitoring systems can interface with a trusted computer system located at a remote site. Numerous techniques of authentication are disclosed that can enable the detection of counterfeit components, such as a counterfeit sensor control device.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Inventors: Michael R. Love, Mark Sloan, Glenn Berman, Nathan Crouther, Gil Porat
  • Publication number: 20220075864
    Abstract: Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Inventors: Glenn Berman, Nathan Crouther, Michael R. Love, Mark Sloan
  • Patent number: 11213622
    Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: January 4, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
  • Patent number: 11159621
    Abstract: Systems, devices, and methods are provided for the management of multiple sensor control devices and/or multiple reader devices in an in vivo analyte monitoring environment, and also for resolving conflicts when merging data collected by different reader devices.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: October 26, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Mark Sloan, Nathan C. Crouther, Glenn Berman, Gil Porat, Michael R. Love
  • Patent number: 11122043
    Abstract: Systems, devices, and methods are provided that allow the authentication of devices within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a reader device for communicating with the sensor control device. The analyte monitoring systems can interface with a trusted computer system located at a remote site. Numerous techniques of authentication are disclosed that can enable the detection of counterfeit components, such as a counterfeit sensor control device.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: September 14, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Michael R. Love, Mark Sloan, Glenn Berman, Nathan Crouther, Gil Porat
  • Publication number: 20200016338
    Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.
    Type: Application
    Filed: September 4, 2019
    Publication date: January 16, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
  • Publication number: 20190369083
    Abstract: Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.
    Type: Application
    Filed: August 15, 2019
    Publication date: December 5, 2019
    Inventors: Michael R. Love, Michael J. Fullmer, Kurt E. Leno, Xuandong Hua, Mark Sloan, Lei He, Glenn Berman
  • Publication number: 20190364111
    Abstract: Systems, devices, and methods are provided for the management of multiple sensor control devices and/or multiple reader devices in an in vivo analyte monitoring environment, and also for resolving conflicts when merging data collected by different reader devices.
    Type: Application
    Filed: June 27, 2019
    Publication date: November 28, 2019
    Inventors: Mark Sloan, Nathan C. Crouther, Glenn Berman, Gil Porat, Michael R. Love
  • Publication number: 20190354674
    Abstract: Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.
    Type: Application
    Filed: June 7, 2019
    Publication date: November 21, 2019
    Inventors: Glenn Berman, Nathan Crouther, Michael R. Love, Mark Sloan
  • Patent number: 10360368
    Abstract: Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: July 23, 2019
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Glenn Berman, Nathan Crouther, Michael R. Love, Mark Sloan
  • Publication number: 20190190913
    Abstract: Systems, devices, and methods are provided that allow the authentication of devices within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a reader device for communicating with the sensor control device. The analyte monitoring systems can interface with a trusted computer system located at a remote site. Numerous techniques of authentication are disclosed that can enable the detection of counterfeit components, such as a counterfeit sensor control device.
    Type: Application
    Filed: October 3, 2018
    Publication date: June 20, 2019
    Inventors: Michael R. Love, Mark Sloan, Glenn Berman, Nathan Crouther, Gil Porat
  • Patent number: 10110603
    Abstract: Systems, devices, and methods are provided that allow the authentication of devices within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a reader device for communicating with the sensor control device. The analyte monitoring systems can interface with a trusted computer system located at a remote site. Numerous techniques of authentication are disclosed that can enable the detection of counterfeit components, such as a counterfeit sensor control device.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: October 23, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Michael R. Love, Mark Sloan, Glenn Berman, Nathan Crouther, Gil Porat